SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Aug 18, 2021
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Purchase
Common Stock
2021-08-17$2.73/sh+3,750$10,238→ 34,641 total(indirect: By Trust)
Holdings
- 60,224
Common Stock
Footnotes (1)
- [F1]Includes shares previously held by the Reporting Person directly, but subsequently transferred to the H. Ralph Snodgrass Living Trust, dated 10/2/2008.